JMP keeps St. Jude Medical at strong buy

St. Jude Medical, Inc. was maintained by JMP Securities analyst Robert Faulkner at a strong buy rating. JMP raised its 2006 sales and earnings-per-share estimates to $$3.527 billion ($185 million from the ANSI acquisition) and $1.80 from $3.148 billion and $1.76. Shares of the St. Paul, Minn., medical device company were down 43 cents, or 0.86%, at $49.60 on volume of 3,606,000 shares versus the three-month running average of 2,087,800 shares. (NYSE: STJ)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.